| | Identification | Back Directory |  | [Name] 
 1-(BENZYLOXYCARBONYL) AZETIDINE-3-CARBOXYLIC ACID
 |  | [CAS] 
 97628-92-7
 |  | [Synonyms] 
 1-Cbz-azetidine-3-carboxy...
 Cbz-3-Azetidinecarboxylic acid
 CBZ-AZETIDINE-3-CARBOXYLIC ACID
 1-Cbz-azetidine-3-carboxylic acid
 N-Cbz-azetidine-3-carboxylic acid
 N-Carbobenzyloxyazetidine-3-carboxylic acid
 Azetidine-1,3-dicarboxylic acid 1-benzyl ester
 1-benzyloxycarbonyl-3-azetidinecarboxylic acid
 1-(BENZYLOXYCARBONYL) AZETIDINE-3-CARBOXYLIC ACID
 1-phenylmethoxycarbonylazetidine-3-carboxylic acid
 N-(Benzyloxycarbonyl)azetidine-3-carboxylic acid, 95%
 1,3-Azetidinedicarboxylic acid, 1-(phenylmethyl) ester
 1-(BENZYLOXYCARBONYL) AZETIDINE-3-CARBOXYLIC ACID ISO 9001:2015 REACH
 |  | [Molecular Formula] 
 C12H13NO4
 |  | [MDL Number] 
 MFCD09027504
 |  | [MOL File] 
 97628-92-7.mol
 |  | [Molecular Weight] 
 235.236
 | 
 | Chemical Properties | Back Directory |  | [Boiling point ] 
 421.2±45.0 °C(Predicted)
 |  | [density ] 
 1.362
 |  | [storage temp. ] 
 2-8°C
 |  | [form ] 
 Solid
 |  | [pka] 
 4.19±0.20(Predicted)
 |  | [color ] 
 White to off-white
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 1-Cbz-azetidine-3-carboxylic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-Cbz-azetidine-3-carboxylic acid is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]
 |  | [Synthesis] 
 
 General procedure for the synthesis of 1-(benzyloxycarbonyl)azetidine-3-carboxylic acid from 3-acridinecarboxylic acid and benzyl chloroformate: 3-acridinecarboxylic acid (4.0 g, 39.6 mmol) was dissolved in a 1 N sodium hydroxide solution (40 mL) and the solution was cooled to 0 °C. Under stirring, benzyl chloroformate (5.9 mL, 41 mmol) was slowly added, followed by dropwise addition of additional 1 N sodium hydroxide solution (41 mL). The reaction mixture was stirred vigorously at 0 °C for 16 hours. Upon completion of the reaction, the mixture was acidified to a pH of about 2-3 with 2 N hydrochloric acid.The acidified suspension was extracted with dichloromethane (2 x 100 mL) and the organic layers were combined and dried with anhydrous magnesium sulfate. After filtration, the organic phase was concentrated under reduced pressure to afford the white solid product 1-(benzyloxycarbonyl)azetidine-3-carboxylic acid (9.3 g, 39.6 mmol, 100% yield). The structure of the product was confirmed by 1H NMR (400 MHz, CDCl3): δ 7.37-7.29 (5H, m, Ar-H), 5.10 (2H, s, CH2Ph), 4.21 (4H, d, J = 7.5 Hz, NCH2), 3.43 (1H, quintuple peak, J = 7.5 Hz, CH). |  | [IC 50] 
 Non-cleavable Linker
 |  | [References] 
 [1] Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315-337. DOI:10.1038/nrd.2016.268
 [2] Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985. DOI:10.7554/eLife.57277
 | 
 |  |